334 related articles for article (PubMed ID: 36902639)
1. What's New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).
Kosmalski M; Frankowski R; Ziółkowska S; Różycka-Kosmalska M; Pietras T
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902639
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds.
Kosmalski M; Frankowski R; Deska K; Różycka-Kosmalska M; Pietras T
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447164
[TBL] [Abstract][Full Text] [Related]
4. Diabetes drugs for nonalcoholic fatty liver disease: a systematic review.
Blazina I; Selph S
Syst Rev; 2019 Nov; 8(1):295. PubMed ID: 31783920
[TBL] [Abstract][Full Text] [Related]
5. Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study).
Ozaki A; Yoneda M; Kessoku T; Iwaki M; Kobayashi T; Honda Y; Ogawa Y; Imajo K; Sakai E; Taguri M; Yamanaka T; Iwasaki T; Kurihashi T; Saito S; Nakajima A
Contemp Clin Trials Commun; 2020 Mar; 17():100516. PubMed ID: 31956725
[TBL] [Abstract][Full Text] [Related]
6. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.
Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagström H; Stål P
JHEP Rep; 2021 Jun; 3(3):100256. PubMed ID: 33898960
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Luo Q; Wei R; Cai Y; Zhao Q; Liu Y; Liu WJ
Front Med (Lausanne); 2022; 9():793203. PubMed ID: 35280867
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
BMJ Open; 2017 Jul; 7(7):e016914. PubMed ID: 28698350
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
[TBL] [Abstract][Full Text] [Related]
10. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.
Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD
Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
Front Immunol; 2022; 13():949746. PubMed ID: 36159792
[TBL] [Abstract][Full Text] [Related]
12. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
Africa JA; Newton KP; Schwimmer JB
Dig Dis Sci; 2016 May; 61(5):1375-86. PubMed ID: 27041377
[TBL] [Abstract][Full Text] [Related]
13. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
[TBL] [Abstract][Full Text] [Related]
14. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.
Abenavoli L; Greco M; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805669
[TBL] [Abstract][Full Text] [Related]
15. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials.
Mantovani A; Byrne CD; Scorletti E; Mantzoros CS; Targher G
Diabetes Metab; 2020 Nov; 46(6):427-441. PubMed ID: 31923578
[TBL] [Abstract][Full Text] [Related]
17. Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review.
Mascaró CM; Bouzas C; Tur JA
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010923
[TBL] [Abstract][Full Text] [Related]
18. An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease.
Perumpail BJ; Cholankeril R; Yoo ER; Kim D; Ahmed A
Diseases; 2017 Oct; 5(4):. PubMed ID: 29065499
[No Abstract] [Full Text] [Related]
19. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE
BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541
[TBL] [Abstract][Full Text] [Related]
20. The impact of health status, diet and lifestyle on non-alcoholic fatty liver disease: Narrative review.
Alalwani J; Eljazzar S; Basil M; Tayyem R
Clin Obes; 2022 Aug; 12(4):e12525. PubMed ID: 35412016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
